142 related articles for article (PubMed ID: 3470047)
1. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic studies of imipenem/cilastatin in elderly patients.
Finch RG; Craddock C; Kelly J; Deaney NB
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():103-7. PubMed ID: 3469182
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
[TBL] [Abstract][Full Text] [Related]
4. Multiple-dose pharmacokinetics of imipenem-cilastatin.
Drusano GL; Standiford HC; Bustamante C; Forrest A; Rivera G; Leslie J; Tatem B; Delaportas D; MacGregor RR; Schimpff SC
Antimicrob Agents Chemother; 1984 Nov; 26(5):715-21. PubMed ID: 6595963
[TBL] [Abstract][Full Text] [Related]
5. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.
Norrby SR; Rogers JD; Ferber F; Jones KH; Zacchei AG; Weidner LL; Demetriades JL; Gravallese DA; Hsieh JY
Antimicrob Agents Chemother; 1984 Nov; 26(5):707-14. PubMed ID: 6595962
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of imipenem and cilastatin in volunteers.
Rogers JD; Meisinger MA; Ferber F; Calandra GB; Demetriades JL; Bland JA
Rev Infect Dis; 1985; 7 Suppl 3():S435-46. PubMed ID: 3863219
[TBL] [Abstract][Full Text] [Related]
8. Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
Gibson TP; Demetriades JL; Bland JA
Am J Med; 1985 Jun; 78(6A):54-61. PubMed ID: 3859216
[TBL] [Abstract][Full Text] [Related]
9. Renal clearance of imipenem in children.
Jacobs RF; Kearns GL; Brown AL; Trang JM; Kluza RB
Eur J Clin Microbiol; 1984 Oct; 3(5):471-4. PubMed ID: 6594236
[TBL] [Abstract][Full Text] [Related]
10. [Penetration of imipenem/cilastatin sodium into the tissues of the female reproductive organs].
Maeda Y; Sengoku K; Mure K; Yamashita K; Shimizu T
Jpn J Antibiot; 1986 May; 39(5):1337-41. PubMed ID: 3463779
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI
Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422
[TBL] [Abstract][Full Text] [Related]
12. [Bone concentrations of imipenem after a dose of imipenem/cilastatin].
Wittmann DH; Kuipers TH; Fock R; Höll M; Bauernfeind A
Infection; 1986; 14 Suppl 2():S130-7. PubMed ID: 3463540
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
[TBL] [Abstract][Full Text] [Related]
14. [A study on the penetration of imipenem/cilastatin sodium into the female genital tissues].
Hongo M; Shimizu R; Sakae K; Kohchi T; Tada K; Tani M
Jpn J Antibiot; 1986 May; 39(5):1389-400. PubMed ID: 3463785
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of imipenem-cilastatin in neonates.
Freij BJ; McCracken GH; Olsen KD; Threlkeld N
Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
Drusano GL; Standiford HC
Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
[TBL] [Abstract][Full Text] [Related]
17. Imipenem/cilastatin therapy for serious bacterial infections.
Nielsen DM; Katz JR; AhLoy RD; Hansen RS; Meyer RD
Rev Infect Dis; 1985; 7 Suppl 3():S506-12. PubMed ID: 3901214
[TBL] [Abstract][Full Text] [Related]
18. Imipenem/cilastatin: rationale for a fixed combination.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 3():S447-51. PubMed ID: 3863220
[TBL] [Abstract][Full Text] [Related]
19. [Fundamental study of imipenem/cilastatin sodium in obstetrics and gynecology].
Taguchi K; Saito Y; Seki H; Murata M; Shidara Y; Sayama T; Sato Y; Isobe K
Jpn J Antibiot; 1986 Jun; 39(6):1514-8. PubMed ID: 3463792
[TBL] [Abstract][Full Text] [Related]
20. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M
Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
